{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:46:01Z","timestamp":1782708361896,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    ADPKD is a progressive cystic disorder characterized by increasing total kidney volume (TKV), declining kidney function, and limited disease-modifying options. Emerging preclinical and clinical evidence suggests metabolic interventions may influence cyst growth, but longitudinal imaging data in humans remain limited. We conducted a retrospective case series of four self-referred individuals (ages 33\u201371) with genetically confirmed truncating PKD1 variants who independently implemented metabolic interventions of varying duration and intensity, including carbohydrate restriction, intermittent fasting, and supplementation with a ketone- and citrate-based medical food (KetoCitra\n                    <jats:sup>\u00ae<\/jats:sup>\n                    ). Intervention periods ranged from 6\u202fmonths to approximately 4\u202fyears and followed prior phases of documented kidney volume enlargement. Serial abdominal imaging obtained during routine clinical care was re-analyzed using standardized volumetric software to assess TKV, liver volume, and Mayo imaging classification trajectories. Across all four cases, stabilization or reduction in TKV relative to prior growth trends was observed during intervention periods, accompanied by preserved kidney function. One participant transitioned from Mayo Class 1C to 1B, while the remaining three demonstrated downward shifts in Mayo imaging trajectory within their existing classifications. Reductions or attenuated increases in liver volume were also observed in cases with polycystic liver disease. Interventions were reported to be feasible and well tolerated, with no serious adverse events. These observations align with emerging preclinical and clinical evidence suggesting metabolic interventions may attenuate TKV progression in ADPKD. While limited by sample size and intervention heterogeneity, this case series provides hypothesis-generating data to inform prospective controlled trials.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2026.1843178","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:26:39Z","timestamp":1782707199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Halting cyst progression in ADPKD using long-term ketogenic metabolic therapy and supplementation with exogenous ketones and alkaline citrate\u2014a case series"],"prefix":"10.3389","volume":"13","author":[{"given":"Melina","family":"Messing","sequence":"first","affiliation":[{"name":"Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara","place":["Santa Barbara, CA, United States"]},{"name":"Santa Barbara Nutrients, Inc.","place":["Santa Barbara, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Muensterman","sequence":"additional","affiliation":[{"name":"Santa Barbara Nutrients, Inc.","place":["Santa Barbara, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Marcon","sequence":"additional","affiliation":[{"name":"Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara","place":["Santa Barbara, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weimbs","sequence":"additional","affiliation":[{"name":"Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara","place":["Santa Barbara, CA, United States"]},{"name":"Santa Barbara Nutrients, Inc.","place":["Santa Barbara, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ekir.2021.09.013","article-title":"PKD1 compared with PKD2 genotype and cardiac hospitalizations in the halt progression of polycystic kidney disease studies","volume":"7","author":"Steele","year":"2021","journal-title":"Kidney Int Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.3390\/nu16193281","article-title":"Trigger warning: how modern diet, lifestyle, and environment pull the trigger on autosomal dominant polycystic kidney disease progression","volume":"16","author":"Messing","year":"2024","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"F352","DOI":"10.1152\/ajprenal.00205.2023","article-title":"A combination of \u03b2-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease","volume":"326","author":"Torres","year":"2024","journal-title":"Ame J Physiol Renal Physiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"110773","DOI":"10.1016\/j.isci.2024.110773","article-title":"\u03b2-Hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease","author":"Torres","year":"2024","journal-title":"iScience"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e004101","DOI":"10.1136\/bmjdrc-2024-004101","article-title":"The case for a ketogenic diet in the management of kidney disease","volume":"12","author":"Athinarayanan","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101283","DOI":"10.1016\/j.xcrm.2023.101283","article-title":"Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial","volume":"4","author":"Cukoski","year":"2023","journal-title":"Cell Rep Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"gfae069-0738","DOI":"10.1093\/ndt\/gfae069.738","article-title":"#2160 ketosis moderates the effect on kidney volume in dietary interventions for ADPKD\u2014more insights on the KETO ADPKD trial","volume":"39","author":"Cukoski","year":"2024","journal-title":"Nephrol Dialysis Transplantation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnut.2025.1624639","article-title":"Real-world outcomes of managing autosomal-dominant polycystic kidney disease using a medical food as part of a nutrition and lifestyle program to improve renal and metabolic health","volume":"12","author":"Muensterman","year":"2026","journal-title":"Front Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/ckj\/sfab162","article-title":"Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects","volume":"15","author":"Strubl","year":"2022","journal-title":"Clin Kidney J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/kidneydial2020020","article-title":"Ren.Nu, a dietary program for individuals with autosomal-dominant polycystic kidney disease implementing a sustainable, plant-focused, kidney-safe, ketogenic approach with avoidance of renal stressors","volume":"2","author":"Bruen","year":"2022","journal-title":"Kidney Dialysis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"10-1681","DOI":"10.1681\/ASN.2025zqnnmtrv","article-title":"Three-month interim analysis of ketogenic metabolic therapy in Japanese patients with ADPKD: SA-PO0579","volume":"36","author":"Kawano","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"nzab144","DOI":"10.1093\/cdn\/nzab144","article-title":"Elevated LDL cholesterol with a carbohydrate-restricted diet: evidence for a \u201clean mass hyper-responder\u201d phenotype","volume":"6","author":"Norwitz","year":"2022","journal-title":"Curr Dev Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacl.2022.10.010","article-title":"Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research","volume":"16","author":"Norwitz","year":"2022","journal-title":"J Clin Lipidol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1381\/096089206777346682","article-title":"Change in liver size and fat content after treatment with Optifast very low calorie diet","volume":"16","author":"Lewis","year":"2006","journal-title":"Obes Surg"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/oby.2062","article-title":"Effects of dietary interventions on liver volume in humans","volume":"22","author":"Bian","year":"2014","journal-title":"Obesity"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/diseases9020039","article-title":"Incidence and characteristics of kidney stones in patients on ketogenic diet: a systematic review and Meta-analysis","volume":"9","author":"Acharya","year":"2021","journal-title":"Diseases"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1681\/ASN.0000000904","article-title":"Automatically measuring kidney, liver, and cyst volumes in autosomal dominant polycystic kidney disease","volume":"37","author":"Xiong","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1843178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:26:40Z","timestamp":1782707200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1843178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":21,"alternative-id":["10.3389\/fnut.2026.1843178"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1843178","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1843178"}}